Inhibition of the sodium–iodide symporter (NIS) has been identified as a key molecular initiating event disrupting the TH system across species, with significant relevance for diagnostic and therapeutic applications in various carcinomas. This evidence concerns the gene SLC5A5 and carcinoma.